Download - HIV & AIDS Prevention
-
8/6/2019 HIV & AIDS Prevention
1/48
DR ATABO AMODU (FWACP)CONSULTANT FAMILY PHYSICIAN
DEPARTMENT OF FAMILY MEDICINEFEDERAL MEDICAL CENTRE MAKURDI
HIV & AIDS Prevention
-
8/6/2019 HIV & AIDS Prevention
2/48
OUTL INE
y Introduction (HIV/AIDS)
y Mode of transmission
y prevention
y Conclusion
-
8/6/2019 HIV & AIDS Prevention
3/48
HIVy HIV is the simplest, most primitive life form on
earth.
y
HIV is unable to replicate (reproduce) on its ownand must first infect a living cell in order toreplicate.
y
HIV is a retrovirus . A retrovirus is an RNAvirus which uses DNA as an intermediary for itsreplication.
-
8/6/2019 HIV & AIDS Prevention
4/48
y HIV is a virus that is in the body of infected persons and ispresent in high amounts (without treatment) in the blood,semen, or genital tract.
HIV
-
8/6/2019 HIV & AIDS Prevention
5/48
y Fundamental pathology is the inability of the hostimmune system to eradicate HIV infection, whichresults in a progressive destruction of the immunesystem.
HIV
HIV
HIV
HIV
HIV
-
8/6/2019 HIV & AIDS Prevention
6/48
-
8/6/2019 HIV & AIDS Prevention
7/48
Gl oba l Picture:
F ourth lead ing cause of mort ality in the wor ld
Esti ma te d 42 m illion persons living w ith HIV/AIDS
About one-thir d a re bet ween 15-24 years
Most peop le are un awa re they are infe cte d
Young women are more vu lner abl e
-
8/6/2019 HIV & AIDS Prevention
8/48
-
8/6/2019 HIV & AIDS Prevention
9/48
Nigeriay the HIV prevalence rate among adults ages 15-49 is 3.9
percent.y Nigeria has the third-largest number of people living with
HIV.y 2009, there were 3.3 million people living withHIV.y Approximately 220,000 people died fromAIDSin Nigeria in
2009.
-
8/6/2019 HIV & AIDS Prevention
10/48
-
8/6/2019 HIV & AIDS Prevention
11/48
HIV ESTIMATES IN NI G ERIA
20052005 20062006 20102010
No of people infectedNo of people infected 2.86 m2.86 m 2.99m2.99m 3.4m3.4m
No of new HIV infections:No of new HIV infections:A dults A dults
Children (
-
8/6/2019 HIV & AIDS Prevention
12/48
Mode of transmission
y Sexu al inter course
receptive anal intercoursereceptive vaginal intercourseinsertive vaginal intercourseinsertive anal intercourse
y C ont amin ate d nee dl es
intr avenous drug users
nee dl e sti ck injuries
inje ction
-
8/6/2019 HIV & AIDS Prevention
13/48
y Mother child
in utero
at birth
breast milk
-
8/6/2019 HIV & AIDS Prevention
14/48
y O rg an / tissue don ation
bloo d /bl oo d pro duct
semen
k idneys
sk in, bone ma rro w, corne as, he art valves, ten dons et c.
-
8/6/2019 HIV & AIDS Prevention
15/48
Ways Someone Can Get HIVWays Someone Can Get HIV
-
8/6/2019 HIV & AIDS Prevention
16/48
PREVENTIO N
EDUC ATIO N.y Education is the cornerstones of HIV prevention strategy.
y Many infections are passed on by those who do not know that
they are infected.
-
8/6/2019 HIV & AIDS Prevention
17/48
TY PE OF EDUC ATIO N
y Talk s
Schoo ls
C hur ches / Mosques
O
rg aniz ations
Wor kp lac es
-
8/6/2019 HIV & AIDS Prevention
18/48
y Wor kshops
Workshops give people chance to people to discuss issues in more detail
y
P lays, songs and m usi c.
y C omm unity meetings
y Door to door
y P amph lets
y Newspapers / rad io
-
8/6/2019 HIV & AIDS Prevention
19/48
Preventing Sexua l Transmission:y ABC -P lus Str ategy
A..Ab stain /d elay sexu al d ebut
BB e f aithfu l/ partner re duction
C U se C on doms
-
8/6/2019 HIV & AIDS Prevention
20/48
U se of C ondoms
y The only effective FP method to prevent HIV/STI transmission
and acquisition is the condom
y Male and female condom should be available over the counter
y
Clients should be instructed in proper use
y Consistent use must be emphasized
-
8/6/2019 HIV & AIDS Prevention
21/48
Ma le condom
-
8/6/2019 HIV & AIDS Prevention
22/48
Fema le condom
-
8/6/2019 HIV & AIDS Prevention
23/48
y P lus- MaleCircumcision- Avoid illicitDrug use
- Empower women (educationally/economically)- Increase male/youths involvement-Prevent MTCT-Identify and treat STIs
-
8/6/2019 HIV & AIDS Prevention
24/48
Prevention of HIV TransmissionAmong ID U sy HIV transmission among injection drug users can be reduced
through communitybased peer outreach es th at are linked to:
1. Information, education and communication (IEC) programs forhigh-risk groups.
2. Risk reduction counseling for injection and sexual behavior change
3. Increased access to sterile injecting equipment
4. Increased access to drug dependence treatment
-
8/6/2019 HIV & AIDS Prevention
25/48
Prevention of B loodTransfusion-Re lated Infectionsy Prevent or treat causes of anemia and blood loss
(e.g., malnutrition, malaria, parasitic infestation, pregnanc yrelated anemia) promptly
y
Minimize unnecessary transfusions: Use blood substitutes(crystalloid/colloid) for volume replacement when possibley Select blood donors carefully: Paid or professional donors
are a higher risky
Create a national blood transfusion servicey Screen bloo d supp ly (and b ody org ans and tissue
earmarked for transplantation)
-
8/6/2019 HIV & AIDS Prevention
26/48
U NIVERSAL PRE C AUT IO NS
y Personal protective equipment
y Hand washing
y Needle and sharps handling and disposal
y Disinfection of instruments
y Appropriate disposal of tissues and other contaminated items
-
8/6/2019 HIV & AIDS Prevention
27/48
Exposure to risk Precautions for preventionof transmission of HIV
venepuncture wear glovesuse a closed vacuum system if availablediscard needle and syringe into sharps boxdiscard gloves and swabs into leakproof plastic bag for incinerationlabel blood bottle and request form"inoculation risk"
invasive procedure,surgery, deliveryof a baby
wear gloves and apron, protect your eyes (glasses or protective goggles)discard sharps into sharps box
spilled blood or other body fluids
clear up as soon as possible using available disinfectant (e.g.glutaraldehyde, phenol,sodium hypochlorite)
resuscitation avoid mouth-to-mouth resuscitation(use bag and mask)
laundry disposal wear gloves and aprondispose into leakproof plastic bagswash laundry at high temperatures or with
appropriate chemical disinfectant
-
8/6/2019 HIV & AIDS Prevention
28/48
-
8/6/2019 HIV & AIDS Prevention
29/48
-
8/6/2019 HIV & AIDS Prevention
30/48
-
8/6/2019 HIV & AIDS Prevention
31/48
Postexposure Prophy laxis (PEP)
Defined:A program through which exposed
individuals (health care workers andotherwise) are offered antiretroviralmedication(s) to reduce the risk of HIVtransmission
-
8/6/2019 HIV & AIDS Prevention
32/48
Type of exposure
Percutaneous 0.4% per singleneedle stick
Mucocutaneous 0.09% per exposure
Intact skin theoretical but undocumented risk
-
8/6/2019 HIV & AIDS Prevention
33/48
PEP: Types of F luidy Infectious
y Bloody Amnioticy Pericardialy Pleuraly Asciticy Synovialy CSFy Genital secretions
y Non-Infectiousy Urine, feces (unless visibly contaminated by blood)y Saliva, tears
-
8/6/2019 HIV & AIDS Prevention
34/48
-
8/6/2019 HIV & AIDS Prevention
35/48
RISK FACTO RS
y Q uantity of blood
y Disease status of source patient
y Host defenses
y Post-exposure prophylaxis
-
8/6/2019 HIV & AIDS Prevention
36/48
Post Exposure Prophy laxis(PEP)
y Int ac t skin, mouth or nose: immediately wash w ith soap and wa ter and rinse thorough ly
to re move all potenti ally infe ctious parti cles .
y Cut or punctured skin: allow to bleed fully.
y Eye: flush immediately with water, then irrig ate w ith nor mal saline for 30 minutes .
y C onsi der post exposure prophy laxis if there ris k of tr ansmission:
-
8/6/2019 HIV & AIDS Prevention
37/48
Post Exposure Prophy laxis continuedy HIV testing immediately, 6 weeks, 6
months and 12 monthsy
Treatment, if started, shouldcontinue for 4 weeks.y Prophylaxis should commence as
soon as possible (1-6 hrs of exposure)
-
8/6/2019 HIV & AIDS Prevention
38/48
PEP: C hoosing a Regimeny Low rates of seroconversion make it difficult to study.
y PEP dosage for low risk exposure :- ZDV 250 -300mg bd+Lamivudine 150mg bd.
y PEP dosage for high risk:- ZDV + Lamivudine + Indinavir orEfaviren.
y PEP may have to be individualized according to ARV treatmentstatus of the source patient. Consult HIV specialist in such cases.
-
8/6/2019 HIV & AIDS Prevention
39/48
Rape victim.y Rape victim should receive PEP if the perpetrator tests HIV
positive or if testing the perpetrator is not possible.
-
8/6/2019 HIV & AIDS Prevention
40/48
C omprehensive Package forPM TCT :4 Elements
y Primary prevention for all women
y FP for the prevention of unintended pregnancy in HIV infected women
y Prevention of MTCT in pregnant HIV infected women
y Care and support for HIV infected women, their infants and family
-
8/6/2019 HIV & AIDS Prevention
41/48
Future Directionsy Vacc ines
Global ongoing research to develop vaccines against HIV.Initial vaccines likely to be only about 30- 40% effective.
y
Micro b icidesProducts inserted into vagina to destroy HIV and othermicroorganisms50 or more products now undergoing testing; about 25%
in various stages of clinical trials in humans
-
8/6/2019 HIV & AIDS Prevention
42/48
-
8/6/2019 HIV & AIDS Prevention
43/48
-
8/6/2019 HIV & AIDS Prevention
44/48
-
8/6/2019 HIV & AIDS Prevention
45/48
CO NCLU SIO N
y HIV/AIDS is a global d isaster
y Publ ic he alth pro blem
y Mor b id ity and m ort ality is high
y Adequ ate prevention pr ac tice can re duce this pheno menon to ne ar
zero
-
8/6/2019 HIV & AIDS Prevention
46/48
T hanks for your attention
-
8/6/2019 HIV & AIDS Prevention
47/48
References1. Ball , A.L. 1998. O vervie w: P olicies and I nterventions to ste m HIV-1
epi demics associate d w ith inje cting drug use . In: Drug Inje cting and HIVinfe ction by G. Stimson, DC Des Jar lais & AL Ball. Lon don, UC L P ress
2. F HI. 2001. HIV/AIDS P revention and C are in Resour ce- C onstr aine dSettings: a handb oo k for the design and ma nagement of progr ams. Edite dby Lamptey P R and Gayle HD.
3. Global HIVP
revention Wor king Group . 2002. Global m obilization for HIVprevention: a bl ueprint for action .4. Gross kurth H et al. 1995. Im pact of improve d tre atment of sexu ally
tr ansmitte d d iseases on HIV infe ction in rur al Tanz ani a: A randomize dcontro l tri al. T he Lancet, 346:530-536.
5. HRSA/JH P IEGO . 2001. A gui de to the clini cal ca re of women with HIV.Edite d b y Jean Anderson .
6. Jean Anderson . 2002. C lini cal C are of Wo men Living with HIV/AIDS : Mu ltimedia Tutori als on C D-RO M. JH P IEGO , Baltimore, Mary land.
-
8/6/2019 HIV & AIDS Prevention
48/48
7. Smith, S., T. Green, P. McDermott, S. Schmidt, P. Waibale, andLillian Mworeko. HIV/AIDS Assessment Team Field Visit.Entebbe, Uganda. Synergy/TvT Associates, Inc. and USAID.November-December 2001.
8. UNAIDS. 2002. Report on the global HIV/AIDS epidemic.9. USAID Office of HIV/AIDS. Male Circumcision: Current
epidemiological and field evidence-Program and PolicyImplications for HIV Prevention and Reproductive Health. DraftConference Report, September 18-19, 2002.
10.WHO. 2002. Safety of Injections. Fact Sheet No. 231.
11. Wilkinson D et al. Population based interventions for reducingSTIs including HIV infection (Cochrane Review). In: CochraneLibrary, Issue 1, 2002. Oxford: Update software.